Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mara G Coyle

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
The American Journal of Drug and Alcohol Abuse|December 18, 2009
Characteristics of opioid-using pregnant women who accept or refuse participation in a clinical trial: screening results from the MOTHER studySusan M Stine, Sarah H Heil, Karol Kaltenbach, et al.
The American Journal on Addictions|March 14, 2009
Psychopharmacologic management of opioid-dependent women during pregnancyPeter R Martin, Amelia M Arria, Gabriele Fischer, et al.
The American Journal on Addictions|June 22, 2013
Nonserious adverse events in randomized trials with opioid-dependent pregnant women: direct versus indirect measurementHendrée E Jones, Karol Kaltenbach, Sarah H Heil, et al.
Journal of Addictive Diseases|December 19, 2012
Comments on: Efficacy versus effectiveness of buprenorphine and methadone maintenance in pregnancyHendrée E Jones, Sarah H Heil, Karol Kaltenbach, et al.
Addiction (Abingdon, England)|October 31, 2012
Fetal assessment before and after dosing with buprenorphine or methadoneAmy L Salisbury, Mara G Coyle, Kevin E O'Grady, et al.
The American Journal on Addictions|August 19, 2010
Co-occurring psychiatric symptoms are associated with increased psychological, social, and medical impairment in opioid dependent pregnant womenMargaret M Benningfield, Amelia M Arria, Karol Kaltenbach, et al.
Addiction (Abingdon, England)|October 31, 2012
Buprenorphine treatment of opioid-dependent pregnant women: a comprehensive reviewHendrée E Jones, Sarah H Heil, Andjela Baewert, et al.
Addiction (Abingdon, England)|October 31, 2012
Effect of hepatitis C virus status on liver enzymes in opioid-dependent pregnant women maintained on opioid-agonist medicationLaura F McNicholas, Amber M Holbrook, Kevin E O'Grady, et al.
The New England Journal of Medicine|December 15, 2010
Neonatal abstinence syndrome after methadone or buprenorphine exposureHendrée E Jones, Karol Kaltenbach, Sarah H Heil, et al.
Journal of Substance Abuse Treatment|February 6, 2008
Treatment of opioid-dependent pregnant women: clinical and research issuesHendree E Jones, Peter R Martin, Sarah H Heil, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
The American Journal of Drug and Alcohol Abuse|December 18, 2009
Characteristics of opioid-using pregnant women who accept or refuse participation in a clinical trial: screening results from the MOTHER studySusan M Stine, Sarah H Heil, Karol Kaltenbach, et al.
The American Journal on Addictions|March 14, 2009
Psychopharmacologic management of opioid-dependent women during pregnancyPeter R Martin, Amelia M Arria, Gabriele Fischer, et al.
The American Journal on Addictions|June 22, 2013
Nonserious adverse events in randomized trials with opioid-dependent pregnant women: direct versus indirect measurementHendrée E Jones, Karol Kaltenbach, Sarah H Heil, et al.
Journal of Addictive Diseases|December 19, 2012
Comments on: Efficacy versus effectiveness of buprenorphine and methadone maintenance in pregnancyHendrée E Jones, Sarah H Heil, Karol Kaltenbach, et al.
Addiction (Abingdon, England)|October 31, 2012
Fetal assessment before and after dosing with buprenorphine or methadoneAmy L Salisbury, Mara G Coyle, Kevin E O'Grady, et al.
The American Journal on Addictions|August 19, 2010
Co-occurring psychiatric symptoms are associated with increased psychological, social, and medical impairment in opioid dependent pregnant womenMargaret M Benningfield, Amelia M Arria, Karol Kaltenbach, et al.
Addiction (Abingdon, England)|October 31, 2012
Buprenorphine treatment of opioid-dependent pregnant women: a comprehensive reviewHendrée E Jones, Sarah H Heil, Andjela Baewert, et al.
Addiction (Abingdon, England)|October 31, 2012
Effect of hepatitis C virus status on liver enzymes in opioid-dependent pregnant women maintained on opioid-agonist medicationLaura F McNicholas, Amber M Holbrook, Kevin E O'Grady, et al.
The New England Journal of Medicine|December 15, 2010
Neonatal abstinence syndrome after methadone or buprenorphine exposureHendrée E Jones, Karol Kaltenbach, Sarah H Heil, et al.
Journal of Substance Abuse Treatment|February 6, 2008
Treatment of opioid-dependent pregnant women: clinical and research issuesHendree E Jones, Peter R Martin, Sarah H Heil, et al.
Pageof 3